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We read the article "Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective Study" with interest. 1 Due to advances in the treatment of human immunodeficiency virus (HIV), life expectancy has increased and atherosclerosis has become a major problem for these patients. 2 Instead of infectious diseases and malignancies caused by HIV, cardiovascular diseases (CVD) has become the major cause of mortality.
Psichogiou et al showed that HIV-positive individuals free of diabetes, CVD, and CVD symptoms presented a significant burden of subclinical CVD. 1 Ü nal et al and Ertem et al reported that the Tp-e interval, Tpe/QT ratio, and atrial electromechanical delay are increased in patients with HIV. These novel markers are predictors of cardiac arrhythmias that can be caused by atherosclerosis. 3, 4 By increasing the life expectancy of patients with HIV, the importance of CVD and any association between the 2 have become very important. Unfortunately, with false information, prejudice, and stigmatization, some patients with HIV are withdrawn from or unwilling to participate in scientific studies. 5 More prospective studies concerning CVD in patients with HIV are needed. Patients should be encouraged to participate in such studies and prejudice and misinformation should be prevented. 
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